Decentralized clinical trials (DCTs) offer a more patient-centric approach, reflecting a transformational philosophy for the conduct of clinical trials in which fewer clinic visits are required and patient and caregiver burden is reduced. To achieve this, DCTs deploy a wide range of digital technologies to collect safety and efficacy data from study participants, normally from the comfort of the patient’s own home.
The specific digital technologies used for data collection vary by study but can include telemedicine, wearable/sensor devices, eConsent, electronic clinical outcome assessments (eCOA), and electronic health (eHealth) records. Mobile technologies are often used to replace written diaries with electronic diaries and to collect data from wearable sensor devices. In-home services allow the collection of vitals such as blood pressure and blood samples.
This report contains market size and forecasts of Decentralized Clinical Trials (DCTs) in Global, including the following market information:
Global Decentralized Clinical Trials (DCTs) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Decentralized Clinical Trials (DCTs) market was valued at 7341.6 million in 2021 and is projected to reach US$ 18560 million by 2028, at a CAGR of 14.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Interventional Trials Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Decentralized Clinical Trials (DCTs) include ICON Plc, LEO Innovation Lab, Science 37, PRA Health Sciences, Clinical Ink, Parexel, Medable, Oracle and CRF Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Decentralized Clinical Trials (DCTs) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Decentralized Clinical Trials (DCTs) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Decentralized Clinical Trials (DCTs) Market Segment Percentages, by Type, 2021 (%)
Interventional Trials
Observational Trials
Expanded Access Trials
Global Decentralized Clinical Trials (DCTs) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Decentralized Clinical Trials (DCTs) Market Segment Percentages, by Application, 2021 (%)
Oncology
Cardiovascular Disease
Others
Global Decentralized Clinical Trials (DCTs) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Decentralized Clinical Trials (DCTs) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Decentralized Clinical Trials (DCTs) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Decentralized Clinical Trials (DCTs) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ICON Plc
LEO Innovation Lab
Science 37
PRA Health Sciences
Clinical Ink
Parexel
Medable
Oracle
CRF Health
Medidata
Covance
IQVIA
PPD
PWNHealth, LLC
Medrio